Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
1(17%)
Results Posted
0%(0 trials)
Terminated
1(17%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Terminated1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
75.0%

Trials by Status

terminated117%
unknown117%
active_not_recruiting117%
completed350%

Recent Activity

1 active trials
Showing 5 of 6
active_not_recruiting

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

NCT01915615
terminated

Pelvic Floor Disorders Among Sexual Minoritized Women

NCT05072158
unknown

Trial of Strategies to Communicate Genetic Information to Different Ethnic Subpopulations

NCT03023735
completed

TOURIST 2: Tracking Of Urgent Risks In Swiss Travelers

NCT03262337
completed

Treatment of Choledocolithiasis by Laparoscopic Exploration

NCT04690101
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01915615

HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy

Active Not Recruiting
NCT05072158

Pelvic Floor Disorders Among Sexual Minoritized Women

Terminated
NCT03023735

Trial of Strategies to Communicate Genetic Information to Different Ethnic Subpopulations

Unknown
NCT03262337

TOURIST 2: Tracking Of Urgent Risks In Swiss Travelers

Completed
NCT04690101

Treatment of Choledocolithiasis by Laparoscopic Exploration

Completed
NCT00696683

Establishment of Natural History of Scorpion Envenomation

Completed

All 6 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
6